In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), notice is hereby given of the following meeting:
Name: Advisory Commission on Childhood Vaccines (ACCV).
Date and Time: September 04, 2014, 1:00 p.m. to 5:35 p.m. EDT; September 05, 2014, 9:00 a.m. to 1:45 p.m. EDT.
Place: Parklawn Building (and via audio conference call and Adobe Connect), Conference Room 10-65, 5600 Fishers Lane, Rockville, MD 20857.
The ACCV will meet on Thursday, September 04, 2014, 1:00 p.m. to 5:35 p.m. EDT and Friday, September 05, 2014, 9:00 a.m. to 1:45 p.m. EDT. The public can join the meeting by:
1. (In Person) Persons interested in attending the meeting in person are encouraged to submit a written notification to: Annie Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C-26, 5600 Fishers Lane, Rockville, Maryland 20857 or email: firstname.lastname@example.org. Since this meeting is held in a federal government building, attendees will need to go through a security check to enter the building and participate in the meeting. This written notification is encouraged so that a list of attendees can be provided to make entry through security quicker. Persons may attend in person without providing written notification, but their entry into the building may be delayed due to security checks and the requirement to be escorted to the meeting by a federal government employee. To request an escort to the meeting after entering the building, call Mario Lombre at 301-443-3196. The meeting will be held at the Parklawn Building, Conference Room 10-65, 5600 Fishers Lane, Rockville, Maryland 20857.
2. (Audio Portion) Calling the conference phone number, 877-917-4913, and providing the following information:
Leaders Name: Dr. A. Melissa Houston.
3. (Visual Portion) Connecting to the ACCV Adobe Connect Pro Meeting using the following URL: https://hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work directly, and enter as a guest). Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by following URL: http://www.adobe.com/go/connectpro_overview.
4. Call (301) 443-6634 or send an email to email@example.com if you are having trouble connecting to the meeting site.
Agenda: The agenda items for the September meeting will include, but are not limited to: Updates from the Division of Vaccine Injury Compensation (DVIC), Department of Justice, National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health), and Center for Biologics, Evaluation and Research (Food and Drug Administration); Clarification on Proposed Changes to the Vaccine Injury Table; VICP Outreach Plan; Report from the ACCV Process Workgroup; Review of Vaccine Information Statements; Presentation on Pneumococcal Polysaccharide (Pneumovax 23) and Zoster (Shingles) Vaccine Safety Review; and a Discussion of Proposed Revisions to VAERS Form (2.0). A draft agenda and additional meeting materials will be posted on the ACCV Web site (http://www.hrsa.gov/vaccinecompensation/accv.htm) prior to the meeting. Agenda items are subject to change as priorities dictate.
Public Comment: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C-26, 5600 Fishers Lane, Rockville, MD 20857 or email: firstname.lastname@example.org. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by email, mail or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the public comment period. Public participation and ability to comment will be limited to space and time as it permits.
For further information contact: Anyone requiring information regarding the ACCV should contact Annie Herzog, DVIC, HSB, Start Printed Page 47658HRSA, Room 11C-26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443-6634 or email: email@example.com.
Dated: August 6, 2014.
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2014-19201 Filed 8-13-14; 8:45 am]
BILLING CODE 4165-15-P